(Q45308745)

English

Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

immunohistochemistry

1 reference

based on heuristic

inferred from title

rhabdomyosarcoma

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Jae Seok Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Sun Min Lim

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Jae Kyung Roh

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Yong Jin Cho

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Kyu Ho Shin

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Woo Ik Yang

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Se Hoon Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Hyo Song Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

language of work or name

0 references

publication date

6 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Journal of Clinical Pathology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

67

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

33-39

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma Study

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201655

21 January 2018

Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201655

21 January 2018

Outcomes in paediatric metastatic rhabdomyosarcoma: results of The International Society of Paediatric Oncology (SIOP) study MMT-98.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201655

21 January 2018

Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201655

21 January 2018

An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201655

21 January 2018

Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201655

21 January 2018

Increased ALK gene copy number and amplification are frequent in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201655

21 January 2018

Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201655

21 January 2018

Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201655

21 January 2018

Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201655

21 January 2018

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201655

21 January 2018

Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201655

21 January 2018

ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201655

21 January 2018

Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201655

21 January 2018

Identifiers

10.1136/JCLINPATH-2013-201655

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23922356%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45308745&oldid=1532666630"